Publicação
A critique of the fragility index
| dc.contributor.author | Machado, Tiago | |
| dc.contributor.author | Duarte, Gonçalo Silva | |
| dc.contributor.author | Gonçalves, Nilza C. | |
| dc.contributor.author | Ferreira, Joaquim J. | |
| dc.contributor.author | Costa, João | |
| dc.date.accessioned | 2019-10-23T11:14:48Z | |
| dc.date.available | 2019-10-23T11:14:48Z | |
| dc.date.issued | 2019-10 | |
| dc.description | Copyright © 2019 Elsevier B.V. or its licensors or contributors. | pt_PT |
| dc.description.abstract | In The Lancet Oncology , Joseph Del Paggio and Ian Tannock report on a retrospective analysis of the fragility indices of phase 3 trials used by the US Food and Drug Administration (FDA) to approve anticancer drugs. 1 The authors conclude that “many phase 3 randomised controlled trials supporting FDA-approved anticancer drugs have a low fragility index, challenging confidence for concluding their superiority over control treatments.” Although this interpretation is interesting, we would like to draw attention to several points. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Lancet Oncol. 2019 Oct;20(10):e553 | pt_PT |
| dc.identifier.doi | 10.1016/S1470-2045(19)30581-9. | |
| dc.identifier.issn | 1470-2045 | |
| dc.identifier.uri | http://hdl.handle.net/10451/39924 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Elsevier | pt_PT |
| dc.relation.publisherversion | https://www.thelancet.com/journals/lanonc/issue/current | pt_PT |
| dc.title | A critique of the fragility index | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.startPage | e553 | pt_PT |
| oaire.citation.title | Lancet Oncology | pt_PT |
| person.familyName | Duarte | |
| person.familyName | Ferreira | |
| person.familyName | Costa | |
| person.givenName | Gonçalo | |
| person.givenName | Joaquim J | |
| person.givenName | João | |
| person.identifier | 1624753 | |
| person.identifier | 480560 | |
| person.identifier.ciencia-id | 7D15-5CD6-6159 | |
| person.identifier.orcid | 0000-0001-7802-1897 | |
| person.identifier.orcid | 0000-0003-3950-5113 | |
| person.identifier.orcid | 0000-0002-5831-4921 | |
| person.identifier.rid | L-4920-2015 | |
| person.identifier.scopus-author-id | 7403252466 | |
| person.identifier.scopus-author-id | 55499748300 | |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 06baa442-3f09-4ee2-b0ee-cf3036a26afd | |
| relation.isAuthorOfPublication | 54d84fe7-2cbd-4ddc-bce2-0ff2bd7c4cc9 | |
| relation.isAuthorOfPublication | 0924f405-2d3a-4914-9097-24aa639bd97f | |
| relation.isAuthorOfPublication.latestForDiscovery | 06baa442-3f09-4ee2-b0ee-cf3036a26afd |